http://goldbamboo.com/ L-Tyrosine News from GoldBamboo.com en-us © 2005, Gold Bamboo LLC, All Rights Reserved http://goldbamboo.com/news-a216566.html Pfizer Inc said on Thursday that Sutent(r) (sunitinib malate) has received the European Commission's full marketing authorization for the treatment of advanced and/or metastatic renal cell carcinoma (MRCC), a type of advanced kidney cancer. It is the first multiple receptor tyrosine kinase inhibitor to be approved in the EU for first-line use in MRCC. [click link for full article] Sun, 21 Jan 2007 11:00 EST http://goldbamboo.com/news-a213005.html Pharmacyclics, Inc. (Nasdaq: PCYC) today announced the publication of data characterizing its novel compounds designed to inhibit Bruton's Tyrosine Kinase (Btk). [click link for full article] Tue, 26 Dec 2006 08:00 EST http://goldbamboo.com/news-a206083.html Exelixis, Inc. (Nasdaq: EXEL) announces that the first results from an ongoing Phase I trial of XL184, a small molecule inhibitor of multiple receptor tyrosine kinases (RTKs) implicated in tumor cell growth and angiogenesis, including c-MET and VEGF were reported today. [click link for full article] Fri, 10 Nov 2006 08:00 EST http://goldbamboo.com/news-a200159.html Kyowa Hakko (Dr. Yuzuru Matsuda, President and CEO) announced that it has developed the world's first fermentation-based method for the commercial production of L-Tyrosine. The company plans to start full-scale production in 2007. L-Tyrosine is an amino acid, which are the building blocks of proteins. [click link for full article] Wed, 27 Sep 2006 07:00 EST http://goldbamboo.com/news-a200398.html Kyowa Hakko today announced that it has developed the world's first fermentation-based method for the commercial production of L-Tyrosine. The company plans to start full-scale production in 2007.L-Tyrosine is an amino acid that is used as a nutritional ingredient in amino acid infusions and enteral nutritional products (medical foods). [click link for full article] Thu, 28 Sep 2006 07:00 EST